Sort
23,748 grants matching “melanoma”
Communication Intervention with Melanoma Families
$669,350Fred Hutchinson Cancer Research Center · R01 · FY2004 · CA
THE IMPACT OF SOMATIC HEMATOPOIETIC MUTATIONS ON MELANOMA TUMORIGENESIS
$669,307Yale Univ · · FY2017 · Department of the Army
Noninvasive Contrast Enhanced Early Detection of Melanoma Liver Metastasis
$668,995Jenny J Yang · Inlighta Biosciences, Llc · R42 · FY2019 · CA
Mechanisms of Cross-talk Between EphrinB and Alternate Signaling Pathways
$668,635Ira Daar · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Signaling Mechanisms of EphrinB1 in Cell Adhesion, Migration and Invasion
$668,635Ira Daar · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Reducing Skin Cancer Risk in Childhood Cancer Survivors
$668,574Alan C Geller · Harvard School Of Public Health · R01 · FY2015 · CA
Molecular ontology of drug tolerant persisters in HER2 positive breast cancer - Resubmission - 1
$668,222Jane Amanda Skok · New York University School Of Medicine · R01 · FY2024 · CA
Leveraging fructose transport to create a privileged substrate to selectively fuel T cells
$668,212Kayvan R Keshari · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA
Immunotherapy of Uveal Melanoma using PRAME Vaccine in Combination with Adoptive T Cell Therapy
$668,196Cassian Yee · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA
Assessment of germline variants associated with immune-related adverse events following immune checkpoint inhibitors
$668,053Toni Choueiri · Dana-Farber Cancer Inst · R01 · FY2025 · CA
Dual-isotope SPECT imaging and immunophenotyping of immune cells to determine response to immunotherapy
$668,018Harriet M Kluger · Yale University · R01 · FY2023 · CA
Role of Neurotrophins in the Development of the Mammalian Nervous System
$667,915Lino Tessarollo · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
PROCESSED ANTIGEN CHARACTERIZATION BY MASS SPECTROMETRY
$667,763Donald F Hunt · University Of Virginia · R37 · FY2008 · AI
Metabolic regulation of immunosuppressive myeloid cells in the tumor microenvironment of pancreatic cancer.
$667,601Yaqing Zhang · University Of Michigan At Ann Arbor · R01 · FY2025 · CA
Development of BRAF Dimer Inhibitors to Treat Drug Resistant Melanoma
$667,564Ronen Marmorstein · University Of Pennsylvania · R01 · FY2019 · CA
Improving Mucosal Melanoma Therapy by Harnessing the Immunogenicity of r3LCMV
$667,553Seth M Pollack · Northwestern University At Chicago · R01 · FY2025 · CA
Targeting Lymphoma: A Multimodal Approach using Radiation, CART-19 Therapy, and Gut Microbiome Modulation
$667,533Andrea Facciabene · University Of Pennsylvania · R01 · FY2025 · CA
Metabolic Engineering for Microbial Taxol Biosynthesis
$667,475Gregory Stephanopoulos · Massachusetts Institute Of Technology · R01 · FY2009 · GM
NCI National Clinical Trials Network-Network Lead Academic Participating Site
$667,303Lawrence E Flaherty · Wayne State University · U10 · FY2018 · CA
Targeting Immunosuppression Pathways to Enhance Brain Tumor Immunotherapy
$667,257John H Sampson · Duke University · P01 · FY2014 · CA
Confocal video-mosaicking microscopy to guide surgery of superficially spreading skin cancers
$667,106Milind Rajadhyaksha · Sloan-Kettering Inst Can Research · R01 · FY2019 · CA
Cancer Resistant Mice
$666,965Bruce A Beutler · Ut Southwestern Medical Center · R01 · FY2023 · CA
Gamma delta T cell based melanoma therapies
$666,701Xiaowei Xu · University Of Pennsylvania · R01 · FY2022 · CA
Role of GPNMB in cardiac remodeling
$666,493Arjun Deb · University Of California Los Angeles · R01 · FY2024 · HL
CANCER AND LEUKEMIA GROUP B
$666,421Brigham And Women'S Hospital · U10 · FY2001 · CA